Nurix Therapeutics, Inc. financial data

Symbol
NRIX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1700 Owens Street, Suite 205, San Francisco, CA
State of incorporation
Delaware
Fiscal year end
November 30
Former names
Nurix, Inc. (to 9/18/2015)
Latest financial report
10-Q - Q2 2024 - Jul 11, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 399 % -12.2%
Debt-to-equity 52.8 % +49.5%
Return On Equity -67.8 % -27%
Return On Assets -44.4 % -12.5%
Operating Margin -195 % +55.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64.4M shares +33.6%
Common Stock, Shares, Outstanding 64.4M shares +35.1%
Entity Public Float 471M USD +6.16%
Common Stock, Value, Issued 64K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 62.4M shares +15%
Weighted Average Number of Shares Outstanding, Diluted 62.4M shares +15%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 80.9M USD +94%
Revenue from Contract with Customer, Excluding Assessed Tax 12.1M USD -60.6%
Research and Development Expense 196M USD +5.96%
General and Administrative Expense 44.9M USD +10.6%
Operating Income (Loss) -179M USD -8.47%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -44.5M USD -83.1%
Income Tax Expense (Benefit) 90K USD
Net Income (Loss) Attributable to Parent -165M USD -4.81%
Earnings Per Share, Basic -2.92 USD/shares +1.02%
Earnings Per Share, Diluted -2.92 USD/shares +1.02%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 117M USD +98.1%
Marketable Securities, Current 217M USD -27.1%
Cash, Cash Equivalents, and Short-term Investments 443M USD +57.6%
Accounts Receivable, after Allowance for Credit Loss, Current 2M USD
Assets, Current 450M USD +55.2%
Property, Plant and Equipment, Net 18.6M USD +0.34%
Operating Lease, Right-of-Use Asset 28.8M USD +190%
Other Assets, Noncurrent 3.14M USD -17.6%
Assets 511M USD +45.7%
Accounts Payable, Current 2.81M USD -37.8%
Employee-related Liabilities, Current 9.17M USD +1.15%
Contract with Customer, Liability, Current 46.8M USD +6.14%
Liabilities, Current 80.8M USD +11.8%
Contract with Customer, Liability, Noncurrent 38.7M USD +163%
Operating Lease, Liability, Noncurrent 20.9M USD +456%
Liabilities 140M USD +54.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -135K USD +92.9%
Retained Earnings (Accumulated Deficit) -631M USD -35.4%
Stockholders' Equity Attributable to Parent 371M USD +42.6%
Liabilities and Equity 511M USD +45.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42M USD +13.4%
Net Cash Provided by (Used in) Financing Activities 1.62M USD +9.66%
Net Cash Provided by (Used in) Investing Activities 35.5M USD +121%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 64.4M shares +35.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.81M USD +84.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 47.6M USD -67.7%
Deferred Tax Assets, Valuation Allowance 194M USD +40%
Deferred Tax Assets, Gross 203M USD +43.1%
Operating Lease, Liability 30.6M USD +156%
Payments to Acquire Property, Plant, and Equipment 2.88M USD +26.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -163M USD -4.47%
Lessee, Operating Lease, Liability, to be Paid 42.4M USD -9.13%
Property, Plant and Equipment, Gross 48.3M USD +15.9%
Operating Lease, Liability, Current 7.93M USD +42.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.57M USD -38.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.65M USD +9.54%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +101%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.8M USD +2652%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.91M USD -32.7%
Deferred Tax Assets, Operating Loss Carryforwards 92.1M USD +9.97%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 15.5M USD +51.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.99M USD +12.1%
Operating Lease, Payments 1.92M USD +38.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 8.94M USD +171%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%